The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes.

@article{Gastaldelli2014TheEO,
  title={The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes.},
  author={Amalia Gastaldelli and Robert G. Brodows and David A D'Alessio},
  journal={Clinical endocrinology},
  year={2014},
  volume={80 4},
  pages={
          545-53
        }
}
OBJECTIVE To determine the effect of chronic daily exenatide treatment on β-cell function in type 2 diabetes (T2DM). BACKGROUND Glucagon-like peptide receptor agonists, such as exenatide, are commonly used to treat patients with T2DM. Drugs in this class are insulinotropic but lower blood glucose by multiple mechanisms such that effects on β-cell function can be difficult to discern by conventional measures. DESIGN Seventy-nine subjects with previously untreated T2DM were studied before and… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

Older Subjects With &bgr;-Cell Dysfunction Have an Accentuated Incretin Release

  • The Journal of clinical endocrinology and metabolism
  • 2018
VIEW 1 EXCERPT
CITES METHODS